CXCL13 and colorectal carcinoma: We found that the anti-CXCL13 antibody or knockdown of CXCR5 in CRC cells could inhibit the activation of the NFκB signaling pathway induced by the CM of miR-934-overexpressing PMA-treated THP-1 cells (Fig. 8b).